Monday, 31 August 2026European Markets

BW ENERGY LIMITED Stock 12.34% Up On Thursday

Loading stream...

(VIANEWS) - The Market ended the session with BW ENERGY LIMITED (BWE.OL) rising 12.34% to kr26.85 on Thursday, after three successive sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 1.12% to kr1,303.97, after two consecutive sessions in a row of losses, on what was an all-around bullish trend trading session today.

BW ENERGY LIMITED's last close was kr23.90, 24.32% below its 52-week high of kr31.58.

About BW ENERGY LIMITED

BW Energy Limited acquires, explores for, develops, and produces oil and natural gas fields in West Africa and Brazil. It holds interests in three hydrocarbon licenses located in Dussafu, Gabon; Maromba, Brazil; and Kudu, Namibia. The company was founded in 2016 and is based in Hamilton, Bermuda.

Earnings Per Share

As for profitability, BW ENERGY LIMITED has a trailing twelve months EPS of kr1.11.

PE Ratio

BW ENERGY LIMITED has a trailing twelve months price to earnings ratio of 24.19. Meaning, the purchaser of the share is investing kr24.19 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 0.72%.

Volume

Today's last reported volume for BW ENERGY LIMITED is 2886580 which is 865.69% above its average volume of 298913.

More news about BW ENERGY LIMITED (BWE.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com